AKBM.OL Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 439 min ago

@ Kr.71.90

Wydano: 3 geg. 2024 @ 14:59

Zwrot: -1.95%

Poprzedni sygnał: geg. 3 - 12:36

Poprzedni sygnał: Sprzedaż

Zwrot: 0.28 %

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 17:25):
Our systems believe the stock currently is undervalued by 0.39% compare to its pairs and should correct upwards.

Stats
Dzisiejszy wolumen	24 947.00
Średni wolumen	50 491.00
Kapitalizacja rynkowa	6.18B
EPS	Kr.0 ( 2024-04-24 )
Następna data zysków	( Kr.0 ) 2024-07-11
Last Dividend	Kr.0 ( N/A )
Next Dividend	Kr.0 ( N/A )
P/E	213.64
ATR14	Kr.4.20 (5.92%)

Korelacja (AI algo v.1.1b): Undervalued: 0.39% Kr.71.18 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Wolumen Korelacja

Długi: -0.97 (very strong negative)

Krótki: 0.00 (neutral)

Signal:(1) Neutral

Aker BioMarine AS Korelacja

10 Najbardziej pozytywne korelacje
PEN.OL	0.93
OKEA.OL	0.907
SBX.OL	0.87
NOL.OL	0.861
AKSO.OL	0.85
ZAL.OL	0.821
SHLF.OL	0.819
ODL.OL	0.819
ELK.OL	0.819
AIRX.OL	0.802

10 Najbardziej negatywne korelacje
TOM.OL	-0.848
CADLR.OL	-0.826
KOMP.OL	-0.813
ATEA.OL	-0.81
HMONY.OL	-0.81

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aker BioMarine AS Korelacja - Waluta/Towar

-0.56
( weak negative )

-0.82
( strong negative )

0.00
( neutral )

-0.38
( neutral )

0.14
( neutral )

0.73
( moderate )

Aker BioMarine AS Finanse

Annual	2023
Przychody:	Kr.335.30M
Zysk brutto:	Kr.112.90M (33.67 %)
EPS:	Kr.-0.100

FY	2023
Przychody:	Kr.335.30M
Zysk brutto:	Kr.112.90M (33.67 %)
EPS:	Kr.-0.100

FY	2022
Przychody:	Kr.277.20M
Zysk brutto:	Kr.114.80M (41.41 %)
EPS:	Kr.0.110

FY	2021
Przychody:	Kr.262.06M
Zysk brutto:	Kr.88.06M (33.60 %)
EPS:	Kr.-0.0900

Financial Reports:

No articles found.

Aker BioMarine AS

Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates through two segments, Ingredients and Brands. It provides Superba, a krill-based ingredients for nutraceutical, including phospholipid complex of choline, omega-3s, and antioxidant astaxanthin; QRILL Aqua, a krill-based ingredients for aquaculture; and QRILL Pet, a krill-based ingredients animal feed application. The company also offers LYSOVETA, a delivery platform based on LPC-bound EPA and DHA from krill; and INVI, a hydrolyzed protein isolate for food and beverage applications. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles waste and re-use materials. The company was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.